Flashpoint Therapeutics Announces Publication Demonstrating Superior Pre-Clinical Anti-Leukemia Efficacy with its Structural Nanomedicine Platform – Business Wire

  1. Flashpoint Therapeutics Announces Publication Demonstrating Superior Pre-Clinical Anti-Leukemia Efficacy with its Structural Nanomedicine Platform  Business Wire
  2. Q&A: Postdoc Taokun Luo explains new nanomedicine that eradicates leukemia in mice 64…

Continue Reading